SLE patients whose elevated and disease-driving type I IFNs are restricted to isoforms of IFNα, which are predominantly made by immune cells via TLR7/9 in response to circulating immune complexes that contain nucleic acids. Here, IFNA1 is linked to systemic lupus erythematosus.